5th International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma
Le Méridien Delfina Santa Monica
Santa Monica, California
May 02, 2015
Download: [ PDF ]
Malignant pleural mesothelioma (MPM) is an unusual cancer because it grows throughout the chest cavity as a diffuse process rather than a typical solid nodule or mass. Because of this unique characteristic, it has very specific treatment issues. MPM also is an unusual tumor with less than 3,000 new cases annually, and therefore, most physicians, even pulmonologists and medical oncologists, may only see these patients infrequently. Despite this, it is critical that all physicians involved in the care of MPM patients be familiar with the important issues in this disease and possess a thorough understanding regarding the tumor itself, its evaluation process, staging, treatment and the role of multidisciplinary management of these patients. This includes the role and extent of surgery as well as radiation, chemotherapy and newer targeted therapies. Robert B. Cameron, MD, the course organizer and the Director of the UCLA Comprehensive Mesothelioma Program, has had over 28 years of experience with treating patients with MPM and, in particular, lung-sparing therapies, including pleurectomy and decortication surgical procedures and a number of complementary adjuvant therapies with the goal of treating this deadly disease like a chronic illness, similar to hypertension and diabetes.
Target Audience
- Pulmonary physicians who are frequently involved in patient workups
- Medical oncologists who are frequently involved in patient therapy
- Mesothelioma experts who want to learn/share experiences about lung-sparing therapies
- Patients, family, friends who desire to learn more about the disease
Early enrollment is advised.
Online
To enroll click here
By Mail
Send the completed enrollment form to:
Office of Continuing Medical Education
David Geffen School of Medicine at UCLA
Mesothelioma
10920 Wilshire Blvd., Suite 1060
Los Angeles, CA 90024-6512
By Fax
Fax the enrollment form with charge card information and your authorizing signature to the Office of Continuing Medical Education, David Geffen School of Medicine at UCLA at (310) 794-2624
By Phone
Use your MasterCard, VISA, American Express, or Discover. Call (310) 794-2620.
Registration Fees
Early registration fee (before April 17)
- $150 Physicians
- $100 Nurses
- $50 Family & Patients
- $25 Students*
- $250 Legal Profession
- $225 Physicians
- $150 Nurses
- $75 Family & Patients
- $40 Students
- $500 Legal Profession
Refunds
Cancellations must be received in writing by April 2, 2015 and will be subject to a $75 processing fee. A full refund will be provided if for any reason the course must be cancelled or rescheduled.
Course Chair
Robert B. Cameron, MD, FACS
Professor of Clinical Cardiothoracic Surgery and Surgical Oncology
Director, Comprehensive Mesothelioma Program
David Geffen School of Medicine at UCLA
Chief, Thoracic Surgery
West Los Angeles VA Medical Center
Los Angeles, California
International and Distinguished Faculty
Marc de Perrot, MD, MSc
Associate Professor of Surgery, University of Toronto
Director, Toronto Mesothelioma Research Program
Division of Thoracic Surgery
Toronto General Hospital
Toronto, Canada
J. Andrea McCart, MD, MSc, FRCS(C)
Associate Professor
Department of Surgery, University of Toronto
Toronto General Research Institute
Toronto, Canada
Shilpen Patel, MD, FACRO
Associate Professor, University of Washington Medical Center
Medical Director of the Clinical Outcomes Assessment Program/Foundation for Health Care Quality
Chief of Thoracic Radiation Oncology/Stereotactic Body Radiation Therapy Program Lead
Seattle, Washington
Walter Weder, MD
Professor of Surgery
Head, Division of Thoracic Surgery
University Hospital of Zürich
Zürich, Switzerland
Faculty
Clare Cameron
Executive Director
Pacific Heart, Lung, & Blood Institute
Los Angeles, California
Peter V. Chen, MD
Radiation Oncology
Hoag Family Cancer Institute
Newport Beach, California
Lien Hua-Feng, RN, MSN, NP-C
Nurse Practitioner
Pacific Mesothelioma Center
Pacific Heart, Lung, & Blood Institute
Los Angeles, California
Percy Lee, MD
Associate Professor
Chief, Thoracic Radiation Oncology
Director, Stereotactic Body Radiation Therapy Program
David Geffen School of Medicine at UCLA
Los Angeles, California
Mrs. Mia Lauter
Widow of Famed Actor Ed Lauter
Los Angeles, California
Olga Olevsky, MD
Health Sciences Assistant Clinical Professor
Santa Monica Oncology
David Geffen School of Medicine at UCLA
Santa Monica, California
Linda Reinstein
President/CEO and Co-Founder
Asbestos Disease Awareness Organization (ADAO)
Manhattan Beach, California
Raymond Wong, PhD
Research Scientist
Pacific Meso Center
Pacific Heart, Lung, & Blood Institute
Los Angeles, California
Saturday, May 2, 2015 |
|
| 7:30 | Registration and Breakfast |
| 8:00 | Welcome Robert B. Cameron, MD, FACS |
| Morning Session I: Lung-Sparing Surgical Techniques Moderator: Robert B. Cameron, MD, FACS |
|
| 8:15 | "Extending" Lung-Sparing Surgery to Include the Diaphragm and Pericardium: The Pros and Cons Robert B. Cameron, MD, FACS |
| 8:50 | Transition from EPP to P/D, One Surgeon's Experience Walter Weder, MD |
| 9:25 | Discussion |
| 9:40 | Break |
| Morning Session II: Lung-Sparing Adjuvant Therapies Moderator: Percy Lee, MD |
|
| 9:55 | Surgery for Mesothelioma after Radiation Therapy: Present and Future Marc de Perrot, MD, MSc |
| 10:30 | The Spectrum of Radiation: What "Flavor" to Choose? Shilpen Patel, MD, FACRO |
| 11:05 | Postoperative Tomotherapy: Tissue Targeting and Toxicity Peter V. Chen, MD and Percy Lee, MD |
| 11:40 | Systemic Therapy for Malignant Pleural Mesothelioma: An Update on Immunotherapy, Cancer Stem Cells, and More Olga Olevsky, MD |
| 12:15 | Discussion |
| 12:30 | Lunch |
| Afternoon Session I: Potential Future Adjuvant Therapies Moderators: Robert B. Cameron, MD, FACS and Raymond Wong, PhD |
|
| 1:30 | Combination Oncolytic Virotherapy and Surgical Debulking for Peritoneal Mesothelioma: Preclinical Data J. Andrea McCart, MD, MSc, FRCS(C) |
| 2:00 | Tumor Vaccines TBD |
| 2:30 | Strategies to Enhance Immune-Based Therapies for Mesothelioma Raymond Wong, PhD |
| 3:00 | Discussion |
| 3:15 | Break |
| Afternoon Session II: Supportive Therapies Moderators: Clare Cameron |
|
| 3:30 | Mesothelioma and the Internet: Big Business, Confusion, and Desperation Lien Hua-Feng, RN, MSN, NP-C |
| 3:45 | The Fight Against Asbestos (and Mesothelioma): The Human Cost of Inaction Linda Reinstein |
| 4:00 | Mesothelioma and the Hollywood Film Industry Clare Cameron |
| 4:15 | My Mesothelioma Journey Mia Lauter |
| 4:30 | Discussion |
| 4:45 | Concluding Remarks Robert B. Cameron, MD, FACS |
| 5:00 | Adjourn |
At the completion of this course, participants should be able to:
- understand the role of each modality in multidisciplinary therapies, including surgery, radiation, and chemotherapy
- discuss the indications and contra-indications for surgery
- recognize the pros and cons of lung-sparing surgery for MPM
- understand the need for chronic treatment for MPM
- identify the various types of radiation and their potential role in adjuvant therapy
The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.
The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is "truly independent" and free of commercial influence. In addition to independence, the FDA requires that nonpromotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program's participants. In addition, Accreditation Council for Continuing Medical Education policy now mandates that the provider adequately manages all identified potential conflicts of interest prior to the program. We at UCLA fully endorse the letter and spirit of these concepts.
Conference Location
Le Méridien Delfina Santa Monica
530 Pico Blvd.
Santa Monica, CA 90405
310-399-9344
Accommodations
If you wish to stay at the hotel, please call reservations at 888-627-8532.
Parking
Valet parking is $10. (Please inform the attendant that you are attending the course to receive this rate.)